Comment from Center for Reproductive Rights
AnonymousOpposeAdvocacy
Summary: The Center for Reproductive Rights opposes the citizen petitions requesting that the FDA impose additional regulations on mifepristone based on claims of environmental contamination. They argue that these claims lack scientific evidence, are legally unfounded, and represent "abortion exceptionalism" by targeting mifepristone specifically for abortion use while ignoring similar practices for other medications.
See attached updated comment from the Center for Reproductive Rights. This comment replaces a previous comment from the Center for Reproductive Rights with the tracking number mp6-17xg-nwo1.